Mental health status of transmasculine adults before and after receiving gender affirming hormonal therapy in Gender Health Clinic, King Chulalongkorn Memorial Hospital, Thai Red Cross Society

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250123005

Enrollment

Registered

2025-01-23

Start date

2023-09-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transmasculine Mental health Depression Transmasculine Gender Affirming Hormone Therapy (GAHT) Mental health Depression Anxiety Self-esteem Quality of Life

Interventions

50 transmasculine individuals aged 18-40 years, visiting the Gender Health Clinic at King Chulalongkorn Memorial Hospital for GAHT(testosterone enanthate)

Screening

transmasculine

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Individual who define themselves as transmasculine Seeking for gender affirming hormone therapy Hormone-naive age > 18 years can use and communicate with Thai language

Exclusion criteria

Exclusion criteria: non-binary/asexual underlying disease of psychiatric disorder non-hormone naive, undergoing gender affirming treatment individuals which contraindicate for gender affiriming hormone therapy

Design outcomes

Primary

Measure	Time frame
Depression 6 month PHQ9	—

Secondary

Measure	Time frame
Anxiety 6 month GAD7,self esteem 6 month rosenberg self esteem scale score,quality of life 6 month WHOQOL BREF THAI	—

Countries

Thailand

Contacts

Public ContactNatchanon Nimmanpatcharin

Faculty of Medicine, Chulalongkorn University

nonnlff95@gmail.com0837076788

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026